tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Graig Suvannavejh, 119 are a BUY (67.23%), 52 are a HOLD (29.38%), 6 are a SELL (3.39%).
Analyst Graig Suvannavejh, currently employed at MIZUHO, carries an average stock price target met ratio of 58.28% that have a potential upside of 32.46% achieved within 107 days.
Graig Suvannavejh’s has documented 373 price targets and ratings displayed on 35 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on AXSM, Axsome Therapeutics at 31-Dec-2024.
Analyst best performing recommendations are on ADVM (ADVERUM BIOTECHNOLOGIES).
The best stock recommendation documented was for ADVM (ADVERUM BIOTECHNOLOGIES) at 4/28/2020. The price target of $170 was fulfilled within 7 days with a profit of $48.4 (39.8%) receiving and performance score of 56.86.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$2.5
$0.84 (50.60%)
$9
1 months 15 days ago
(17-Dec-2024)
1/6 (16.67%)
$0.58 (30.21%)
24
Buy
$4
$2.34 (140.96%)
$15
1 months 16 days ago
(16-Dec-2024)
1/5 (20%)
$2.06 (106.19%)
128
Hold
$3
$1.34 (80.72%)
$10
2 months 6 days ago
(26-Nov-2024)
1/6 (16.67%)
$0.4 (15.38%)
332
Buy
$5
$3.34 (201.20%)
$16
2 months 6 days ago
(26-Nov-2024)
1/3 (33.33%)
$2.4 (92.31%)
70
Buy
$35
$33.34 (2008.43%)
$35
2 months 25 days ago
(07-Nov-2024)
0/7 (0%)
$29.36 (520.57%)
Which stock is Graig Suvannavejh is most bullish on?
Which stock is Graig Suvannavejh is most reserved on?
What Year was the first public recommendation made by Graig Suvannavejh?
